In this issue ...
FDA approves quinupristin-dalfopristin for some vancomycin-resistant infections
Epirubicin approved for breast cancer treatment
Sirolimus approved with renal transplant indication
New short-acting neuromuscular blocker released
Site survey, FDA editorial note hazards of prescription drug availability on Internet
With 100 days to Y2K, some health care settings remained vulnerable
Database on patient-assistance programs available
Panel recommends strategies for 'wired' health communication
Medicare drug benefit based on private-sector model proposed
Build information framework for measuring health care quality, says NCQA report
News Briefs
Zanamivir
Managed migraine
Tolcapone: A novel approach to Parkinson's disease
Tolcapone: A novel approach to Parkinson's disease
HMO direct costs and health care resource use after implementation of a monthly limit on sumatriptan
Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation in coronary artery bypass surgery
Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibility
Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid
Treatment of hypercholesterolemia with oral neomycin
Justifying pharmacy staffing by presenting pharmacists as investments through return-on-investment analysis
Transitions in pharmacy practice, part 3: Effecting change-the three-ring circus
Citalopram versus other selective serotonin-reuptake inhibitors
Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia
Evidence-based pharmacy versus opinion on generic product selection of warfarin
Career Opportunities
Journal References
Self-study Materials
Self-study Materials
Self-study Materials
Self-study Materials